212 related articles for article (PubMed ID: 30841449)
21. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation.
Pan T; Zhang M; Zhang F; Yan G; Ru Y; Wang Q; Zhang Y; Wei X; Xu X; Shen L; Zhang J; Wu K; Yao L; Li X
Biochem Biophys Res Commun; 2017 Feb; 483(2):860-866. PubMed ID: 28069379
[TBL] [Abstract][Full Text] [Related]
22. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
[TBL] [Abstract][Full Text] [Related]
24. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.
Hsieh FS; Chen YL; Hung MH; Chu PY; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Chang MJ; Chao TI; Shiau CW; Chen KF
Mol Oncol; 2017 Aug; 11(8):1035-1049. PubMed ID: 28453226
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
Tan J; Song M; Zhou M; Hu Y
Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
[TBL] [Abstract][Full Text] [Related]
27. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
28. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
29. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway.
Zhao Y; Wu H; Xing X; Ma Y; Ji S; Xu X; Zhao X; Wang S; Jiang W; Fang C; Zhang L; Yan F; Wang X
J Pharmacol Exp Ther; 2020 Sep; 374(3):512-520. PubMed ID: 32571958
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.
Xu J; Ren G; Cheng Q
Technol Cancer Res Treat; 2023; 22():15330338231190737. PubMed ID: 37559469
[TBL] [Abstract][Full Text] [Related]
31. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
32. Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration.
Ferretti AC; Hidalgo F; Tonucci FM; Almada E; Pariani A; Larocca MC; Favre C
Sci Rep; 2019 Feb; 9(1):2815. PubMed ID: 30809021
[TBL] [Abstract][Full Text] [Related]
33. ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.
Huang Z; Xia L; Zhou X; Wei C; Mo Q
Biochem Biophys Res Commun; 2019 Jun; 514(1):24-30. PubMed ID: 31014671
[TBL] [Abstract][Full Text] [Related]
34. Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway.
He Z; Peng Y; Duan W; Tian Y; Zhang J; Hu T; Cai Y; Feng Y; Li G
J Toxicol Sci; 2015 Feb; 40(1):127-36. PubMed ID: 25743752
[TBL] [Abstract][Full Text] [Related]
35. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
Kim YW; Jang EJ; Kim CH; Lee JH
Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
[TBL] [Abstract][Full Text] [Related]
36. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling.
Zhu Y; Zhao L; Shi K; Huang Z; Chen B
Exp Cell Res; 2018 Jun; 367(2):274-281. PubMed ID: 29627320
[TBL] [Abstract][Full Text] [Related]
37. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
[TBL] [Abstract][Full Text] [Related]
38. Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model.
Zhang Q; Zhang Y; Wang C; Tang H; Ma A; Gao P; Shi Q; Wang G; Shen S; Zhang J; Xia F; Zhu Y; Wang J
Phytomedicine; 2024 Jul; 129():155657. PubMed ID: 38692076
[TBL] [Abstract][Full Text] [Related]
39. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
[TBL] [Abstract][Full Text] [Related]
40. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
Shan C; Elf S; Ji Q; Kang HB; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
Mol Cell; 2014 Aug; 55(4):552-65. PubMed ID: 25042803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]